Dosing starts at 0.25 mg and titrates to a full adult dose of 2.4 mg
This is our default at InfusaLounge
Consult provider for : Conditions, meds, symptoms
AOD9604, a peptide fragment, is studied in metabolic research
Description Why 5-Amino-1MQ Is Redefining Lipid Metabolism Research Selective NNMT inhibitor -35% fat mass in 11 days without appetite reduction (preclinical model) Enzymatic Target NNMT Inhibitor Selective inhibition of nicotinamide N-methyltransferase (IC50 = 1.2 M)
Downtime ranges from zero (walk in, walk out, go straight back to work or a meeting) to a few days of visible redness, swelling, or pinpoint bruising depending on the protocol